OncoZenge: Engages LINK Medical for feasibility study
4 juni, 09:54
4 juni, 09:54
Redeye comments on OncoZenge’s engagement of LINK Medical to conduct a feasibility study ahead of its European phase III trial for BupiZenge. We view this as a strategically important step in the company's clinical execution plan, aimed at optimizing trial site selection and recruitment timelines in key European markets.
4 juni, 09:54
Redeye comments on OncoZenge’s engagement of LINK Medical to conduct a feasibility study ahead of its European phase III trial for BupiZenge. We view this as a strategically important step in the company's clinical execution plan, aimed at optimizing trial site selection and recruitment timelines in key European markets.
Fortnox-budet
Investmentbolagen
Storbritannien
Aktieråd
Fortnox-budet
Investmentbolagen
Storbritannien
Aktieråd
1 DAG %
Senast
Saab
Igår, 16:31
Stort inflöde till försvars-ETF:er
OMX Stockholm 30
1 DAG %
Senast
2 481,49